This hypothesis is further supported by the facts that (1) only GBM cell lines responding to 2OHOA treatment increase SMS1 expression, and (2) the effect of increasing SMS activity by either SMS1 overexpression or 2OHOA treatment produced similar glioma cell growth inhibition. The gene discussed is SGMS1; the disease is glioblastoma.